nodes	percent_of_prediction	percent_of_DWPC	metapath
Pitavastatin—ABCC2—epilepsy syndrome	0.123	0.379	CbGaD
Pitavastatin—ABCG2—epilepsy syndrome	0.109	0.335	CbGaD
Pitavastatin—UGT1A3—Lamotrigine—epilepsy syndrome	0.054	0.114	CbGbCtD
Pitavastatin—ALB—epilepsy syndrome	0.0474	0.146	CbGaD
Pitavastatin—ABCB1—epilepsy syndrome	0.0452	0.139	CbGaD
Pitavastatin—UGT2B7—Carbamazepine—epilepsy syndrome	0.0336	0.0711	CbGbCtD
Pitavastatin—ABCC2—Levetiracetam—epilepsy syndrome	0.0308	0.065	CbGbCtD
Pitavastatin—UGT1A3—Valproic Acid—epilepsy syndrome	0.0278	0.0587	CbGbCtD
Pitavastatin—UGT2B7—Valproic Acid—epilepsy syndrome	0.0201	0.0424	CbGbCtD
Pitavastatin—ABCC2—Carbamazepine—epilepsy syndrome	0.0177	0.0374	CbGbCtD
Pitavastatin—ALB—Oxcarbazepine—epilepsy syndrome	0.0175	0.0371	CbGbCtD
Pitavastatin—ABCC2—Phenytoin—epilepsy syndrome	0.0158	0.0335	CbGbCtD
Pitavastatin—ALB—Fosphenytoin—epilepsy syndrome	0.0153	0.0324	CbGbCtD
Pitavastatin—ABCC2—Phenobarbital—epilepsy syndrome	0.0141	0.0299	CbGbCtD
Pitavastatin—ALB—Clonazepam—epilepsy syndrome	0.0139	0.0293	CbGbCtD
Pitavastatin—CYP2C8—Trimethadione—epilepsy syndrome	0.0126	0.0266	CbGbCtD
Pitavastatin—CYP2C8—Fosphenytoin—epilepsy syndrome	0.0118	0.025	CbGbCtD
Pitavastatin—ALB—Rufinamide—epilepsy syndrome	0.0113	0.0239	CbGbCtD
Pitavastatin—ABCB1—Levetiracetam—epilepsy syndrome	0.01	0.0212	CbGbCtD
Pitavastatin—ALB—Phenytoin—epilepsy syndrome	0.00988	0.0209	CbGbCtD
Pitavastatin—ALB—Propofol—epilepsy syndrome	0.00921	0.0195	CbGbCtD
Pitavastatin—CYP2C9—Trimethadione—epilepsy syndrome	0.00879	0.0186	CbGbCtD
Pitavastatin—CYP2C8—Carbamazepine—epilepsy syndrome	0.00851	0.018	CbGbCtD
Pitavastatin—ALB—Diazepam—epilepsy syndrome	0.00835	0.0176	CbGbCtD
Pitavastatin—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00826	0.0175	CbGbCtD
Pitavastatin—CYP2C8—Primidone—epilepsy syndrome	0.00794	0.0168	CbGbCtD
Pitavastatin—CYP2C8—Phenytoin—epilepsy syndrome	0.00763	0.0161	CbGbCtD
Pitavastatin—CYP2C8—Propofol—epilepsy syndrome	0.00712	0.0151	CbGbCtD
Pitavastatin—ABCB1—Clobazam—epilepsy syndrome	0.00695	0.0147	CbGbCtD
Pitavastatin—CYP2C8—Phenobarbital—epilepsy syndrome	0.0068	0.0144	CbGbCtD
Pitavastatin—ABCB1—Lamotrigine—epilepsy syndrome	0.00669	0.0141	CbGbCtD
Pitavastatin—CYP2C8—Diazepam—epilepsy syndrome	0.00645	0.0136	CbGbCtD
Pitavastatin—CYP2C9—Carbamazepine—epilepsy syndrome	0.00594	0.0125	CbGbCtD
Pitavastatin—ABCB1—Carbamazepine—epilepsy syndrome	0.00576	0.0122	CbGbCtD
Pitavastatin—CYP2C9—Primidone—epilepsy syndrome	0.00554	0.0117	CbGbCtD
Pitavastatin—CYP2C9—Phenytoin—epilepsy syndrome	0.00532	0.0113	CbGbCtD
Pitavastatin—ABCB1—Phenytoin—epilepsy syndrome	0.00517	0.0109	CbGbCtD
Pitavastatin—CYP2C8—Valproic Acid—epilepsy syndrome	0.00508	0.0107	CbGbCtD
Pitavastatin—CYP2C9—Propofol—epilepsy syndrome	0.00497	0.0105	CbGbCtD
Pitavastatin—CYP2C9—Phenobarbital—epilepsy syndrome	0.00475	0.01	CbGbCtD
Pitavastatin—ABCB1—Phenobarbital—epilepsy syndrome	0.0046	0.00974	CbGbCtD
Pitavastatin—ABCB1—Midazolam—epilepsy syndrome	0.00454	0.0096	CbGbCtD
Pitavastatin—CYP2C9—Diazepam—epilepsy syndrome	0.0045	0.00951	CbGbCtD
Pitavastatin—ABCB1—Diazepam—epilepsy syndrome	0.00437	0.00923	CbGbCtD
Pitavastatin—CYP2C9—Valproic Acid—epilepsy syndrome	0.00355	0.0075	CbGbCtD
Pitavastatin—Rosuvastatin—SLCO1A2—epilepsy syndrome	0.000875	0.251	CrCbGaD
Pitavastatin—Atorvastatin—SLCO1A2—epilepsy syndrome	0.000617	0.177	CrCbGaD
Pitavastatin—SLCO2B1—ganglion—epilepsy syndrome	0.000551	0.0907	CbGeAlD
Pitavastatin—Rosuvastatin—ABCG2—epilepsy syndrome	0.00037	0.106	CrCbGaD
Pitavastatin—Atorvastatin—ABCC2—epilepsy syndrome	0.000295	0.0847	CrCbGaD
Pitavastatin—Rosuvastatin—CYP2C19—epilepsy syndrome	0.000291	0.0835	CrCbGaD
Pitavastatin—HMGCR—forebrain—epilepsy syndrome	0.000273	0.0449	CbGeAlD
Pitavastatin—HMGCR—telencephalon—epilepsy syndrome	0.000251	0.0413	CbGeAlD
Pitavastatin—Fluvastatin—CYP2C19—epilepsy syndrome	0.000235	0.0675	CrCbGaD
Pitavastatin—SLCO2B1—forebrain—epilepsy syndrome	0.000231	0.0381	CbGeAlD
Pitavastatin—SLC10A1—head—epilepsy syndrome	0.000226	0.0372	CbGeAlD
Pitavastatin—SLC10A1—nervous system—epilepsy syndrome	0.000214	0.0352	CbGeAlD
Pitavastatin—SLCO2B1—telencephalon—epilepsy syndrome	0.000213	0.035	CbGeAlD
Pitavastatin—SLC10A1—central nervous system—epilepsy syndrome	0.000206	0.0339	CbGeAlD
Pitavastatin—Atorvastatin—CYP2C19—epilepsy syndrome	0.000205	0.0588	CrCbGaD
Pitavastatin—HMGCR—medulla oblongata—epilepsy syndrome	0.000197	0.0325	CbGeAlD
Pitavastatin—HMGCR—midbrain—epilepsy syndrome	0.00018	0.0297	CbGeAlD
Pitavastatin—HMGCR—spinal cord—epilepsy syndrome	0.000176	0.0289	CbGeAlD
Pitavastatin—Fluvastatin—CYP2D6—epilepsy syndrome	0.000174	0.0501	CrCbGaD
Pitavastatin—SLCO2B1—medulla oblongata—epilepsy syndrome	0.000167	0.0275	CbGeAlD
Pitavastatin—SLC10A1—brain—epilepsy syndrome	0.000164	0.0269	CbGeAlD
Pitavastatin—Rosuvastatin—ALB—epilepsy syndrome	0.000161	0.0463	CrCbGaD
Pitavastatin—HMGCR—head—epilepsy syndrome	0.000156	0.0257	CbGeAlD
Pitavastatin—ORM1—spinal cord—epilepsy syndrome	0.000155	0.0256	CbGeAlD
Pitavastatin—Atorvastatin—CYP2D6—epilepsy syndrome	0.000152	0.0436	CrCbGaD
Pitavastatin—SLCO2B1—spinal cord—epilepsy syndrome	0.000149	0.0245	CbGeAlD
Pitavastatin—HMGCR—nervous system—epilepsy syndrome	0.000148	0.0244	CbGeAlD
Pitavastatin—HMGCR—central nervous system—epilepsy syndrome	0.000143	0.0235	CbGeAlD
Pitavastatin—HMGCR—cerebellum—epilepsy syndrome	0.000139	0.0229	CbGeAlD
Pitavastatin—ABCG2—telencephalon—epilepsy syndrome	0.000133	0.0219	CbGeAlD
Pitavastatin—SLCO2B1—head—epilepsy syndrome	0.000132	0.0218	CbGeAlD
Pitavastatin—ORM1—nervous system—epilepsy syndrome	0.000131	0.0216	CbGeAlD
Pitavastatin—Fatigue—Oxcarbazepine—epilepsy syndrome	0.000128	0.00105	CcSEcCtD
Pitavastatin—Hepatitis—Gabapentin—epilepsy syndrome	0.000127	0.00105	CcSEcCtD
Pitavastatin—Constipation—Phenytoin—epilepsy syndrome	0.000127	0.00105	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Zonisamide—epilepsy syndrome	0.000127	0.00105	CcSEcCtD
Pitavastatin—Asthenia—Levetiracetam—epilepsy syndrome	0.000127	0.00105	CcSEcCtD
Pitavastatin—Pruritus—Midazolam—epilepsy syndrome	0.000127	0.00105	CcSEcCtD
Pitavastatin—Hypoaesthesia—Gabapentin—epilepsy syndrome	0.000127	0.00105	CcSEcCtD
Pitavastatin—Constipation—Oxcarbazepine—epilepsy syndrome	0.000127	0.00105	CcSEcCtD
Pitavastatin—Urticaria—Felbamate—epilepsy syndrome	0.000126	0.00104	CcSEcCtD
Pitavastatin—ORM1—central nervous system—epilepsy syndrome	0.000126	0.0208	CbGeAlD
Pitavastatin—Abdominal pain—Felbamate—epilepsy syndrome	0.000126	0.00104	CcSEcCtD
Pitavastatin—Diarrhoea—Propofol—epilepsy syndrome	0.000126	0.00104	CcSEcCtD
Pitavastatin—Pruritus—Levetiracetam—epilepsy syndrome	0.000125	0.00104	CcSEcCtD
Pitavastatin—SLCO2B1—nervous system—epilepsy syndrome	0.000125	0.0207	CbGeAlD
Pitavastatin—Musculoskeletal discomfort—Lamotrigine—epilepsy syndrome	0.000125	0.00103	CcSEcCtD
Pitavastatin—Dyspepsia—Carbamazepine—epilepsy syndrome	0.000125	0.00103	CcSEcCtD
Pitavastatin—Insomnia—Lamotrigine—epilepsy syndrome	0.000124	0.00103	CcSEcCtD
Pitavastatin—Ill-defined disorder—Valproic Acid—epilepsy syndrome	0.000124	0.00102	CcSEcCtD
Pitavastatin—Headache—Acetazolamide—epilepsy syndrome	0.000124	0.00102	CcSEcCtD
Pitavastatin—Urticaria—Zonisamide—epilepsy syndrome	0.000124	0.00102	CcSEcCtD
Pitavastatin—Feeling abnormal—Clonazepam—epilepsy syndrome	0.000124	0.00102	CcSEcCtD
Pitavastatin—Erectile dysfunction—Topiramate—epilepsy syndrome	0.000123	0.00102	CcSEcCtD
Pitavastatin—Abdominal pain—Zonisamide—epilepsy syndrome	0.000123	0.00102	CcSEcCtD
Pitavastatin—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000123	0.00101	CcSEcCtD
Pitavastatin—Asthenia—Fosphenytoin—epilepsy syndrome	0.000123	0.00101	CcSEcCtD
Pitavastatin—Feeling abnormal—Phenytoin—epilepsy syndrome	0.000123	0.00101	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Clonazepam—epilepsy syndrome	0.000123	0.00101	CcSEcCtD
Pitavastatin—Fatigue—Carbamazepine—epilepsy syndrome	0.000123	0.00101	CcSEcCtD
Pitavastatin—Feeling abnormal—Oxcarbazepine—epilepsy syndrome	0.000122	0.00101	CcSEcCtD
Pitavastatin—Constipation—Carbamazepine—epilepsy syndrome	0.000122	0.001	CcSEcCtD
Pitavastatin—Dizziness—Propofol—epilepsy syndrome	0.000121	0.001	CcSEcCtD
Pitavastatin—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000121	0.001	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Oxcarbazepine—epilepsy syndrome	0.000121	0.001	CcSEcCtD
Pitavastatin—Pruritus—Fosphenytoin—epilepsy syndrome	0.000121	0.000999	CcSEcCtD
Pitavastatin—Hypersensitivity—Diazepam—epilepsy syndrome	0.000121	0.000999	CcSEcCtD
Pitavastatin—Dyspepsia—Lamotrigine—epilepsy syndrome	0.000121	0.000998	CcSEcCtD
Pitavastatin—SLCO2B1—central nervous system—epilepsy syndrome	0.000121	0.0199	CbGeAlD
Pitavastatin—Malaise—Valproic Acid—epilepsy syndrome	0.000121	0.000996	CcSEcCtD
Pitavastatin—Asthenia—Vigabatrin—epilepsy syndrome	0.00012	0.000988	CcSEcCtD
Pitavastatin—Urticaria—Clonazepam—epilepsy syndrome	0.000119	0.000983	CcSEcCtD
Pitavastatin—Dizziness—Midazolam—epilepsy syndrome	0.000119	0.00098	CcSEcCtD
Pitavastatin—Abdominal pain—Clonazepam—epilepsy syndrome	0.000119	0.000978	CcSEcCtD
Pitavastatin—Fatigue—Lamotrigine—epilepsy syndrome	0.000118	0.000978	CcSEcCtD
Pitavastatin—Urticaria—Phenytoin—epilepsy syndrome	0.000118	0.000977	CcSEcCtD
Pitavastatin—SLCO2B1—cerebellum—epilepsy syndrome	0.000118	0.0194	CbGeAlD
Pitavastatin—Pruritus—Vigabatrin—epilepsy syndrome	0.000118	0.000974	CcSEcCtD
Pitavastatin—Asthenia—Diazepam—epilepsy syndrome	0.000118	0.000973	CcSEcCtD
Pitavastatin—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000118	0.000971	CcSEcCtD
Pitavastatin—Constipation—Lamotrigine—epilepsy syndrome	0.000118	0.00097	CcSEcCtD
Pitavastatin—Nausea—Acetazolamide—epilepsy syndrome	0.000117	0.000969	CcSEcCtD
Pitavastatin—Dizziness—Levetiracetam—epilepsy syndrome	0.000117	0.000968	CcSEcCtD
Pitavastatin—Feeling abnormal—Carbamazepine—epilepsy syndrome	0.000117	0.000967	CcSEcCtD
Pitavastatin—Abdominal pain—Oxcarbazepine—epilepsy syndrome	0.000117	0.000967	CcSEcCtD
Pitavastatin—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000117	0.000966	CcSEcCtD
Pitavastatin—Back pain—Pregabalin—epilepsy syndrome	0.000117	0.000966	CcSEcCtD
Pitavastatin—Muscle spasms—Pregabalin—epilepsy syndrome	0.000116	0.00096	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	0.000116	0.00096	CcSEcCtD
Pitavastatin—Pruritus—Diazepam—epilepsy syndrome	0.000116	0.000959	CcSEcCtD
Pitavastatin—Rash—Propofol—epilepsy syndrome	0.000116	0.000955	CcSEcCtD
Pitavastatin—Dermatitis—Propofol—epilepsy syndrome	0.000116	0.000954	CcSEcCtD
Pitavastatin—Headache—Propofol—epilepsy syndrome	0.000115	0.000949	CcSEcCtD
Pitavastatin—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000115	0.000946	CcSEcCtD
Pitavastatin—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000114	0.000942	CcSEcCtD
Pitavastatin—Asthenia—Felbamate—epilepsy syndrome	0.000114	0.000941	CcSEcCtD
Pitavastatin—Arthralgia—Valproic Acid—epilepsy syndrome	0.000114	0.00094	CcSEcCtD
Pitavastatin—Myalgia—Valproic Acid—epilepsy syndrome	0.000114	0.00094	CcSEcCtD
Pitavastatin—Feeling abnormal—Lamotrigine—epilepsy syndrome	0.000113	0.000935	CcSEcCtD
Pitavastatin—Rash—Midazolam—epilepsy syndrome	0.000113	0.000934	CcSEcCtD
Pitavastatin—HMGCR—brain—epilepsy syndrome	0.000113	0.0186	CbGeAlD
Pitavastatin—Dizziness—Fosphenytoin—epilepsy syndrome	0.000113	0.000934	CcSEcCtD
Pitavastatin—Dermatitis—Midazolam—epilepsy syndrome	0.000113	0.000934	CcSEcCtD
Pitavastatin—Urticaria—Carbamazepine—epilepsy syndrome	0.000113	0.000932	CcSEcCtD
Pitavastatin—Discomfort—Valproic Acid—epilepsy syndrome	0.000113	0.000929	CcSEcCtD
Pitavastatin—Headache—Midazolam—epilepsy syndrome	0.000113	0.000928	CcSEcCtD
Pitavastatin—Pruritus—Felbamate—epilepsy syndrome	0.000112	0.000928	CcSEcCtD
Pitavastatin—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000112	0.000928	CcSEcCtD
Pitavastatin—Diarrhoea—Diazepam—epilepsy syndrome	0.000112	0.000927	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.000112	0.000927	CcSEcCtD
Pitavastatin—Ill-defined disorder—Pregabalin—epilepsy syndrome	0.000112	0.000926	CcSEcCtD
Pitavastatin—Rash—Levetiracetam—epilepsy syndrome	0.000112	0.000923	CcSEcCtD
Pitavastatin—Dermatitis—Levetiracetam—epilepsy syndrome	0.000112	0.000922	CcSEcCtD
Pitavastatin—Asthenia—Zonisamide—epilepsy syndrome	0.000112	0.000921	CcSEcCtD
Pitavastatin—Headache—Levetiracetam—epilepsy syndrome	0.000111	0.000917	CcSEcCtD
Pitavastatin—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000111	0.000912	CcSEcCtD
Pitavastatin—Dizziness—Vigabatrin—epilepsy syndrome	0.00011	0.00091	CcSEcCtD
Pitavastatin—Confusional state—Valproic Acid—epilepsy syndrome	0.00011	0.000909	CcSEcCtD
Pitavastatin—Pruritus—Zonisamide—epilepsy syndrome	0.00011	0.000909	CcSEcCtD
Pitavastatin—Hypersensitivity—Phenytoin—epilepsy syndrome	0.00011	0.000906	CcSEcCtD
Pitavastatin—Urticaria—Lamotrigine—epilepsy syndrome	0.000109	0.000901	CcSEcCtD
Pitavastatin—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000109	0.000901	CcSEcCtD
Pitavastatin—Malaise—Pregabalin—epilepsy syndrome	0.000109	0.0009	CcSEcCtD
Pitavastatin—Nausea—Propofol—epilepsy syndrome	0.000109	0.0009	CcSEcCtD
Pitavastatin—Diarrhoea—Felbamate—epilepsy syndrome	0.000109	0.000898	CcSEcCtD
Pitavastatin—Abdominal pain—Lamotrigine—epilepsy syndrome	0.000109	0.000897	CcSEcCtD
Pitavastatin—Dizziness—Diazepam—epilepsy syndrome	0.000109	0.000896	CcSEcCtD
Pitavastatin—Atorvastatin—ABCB1—epilepsy syndrome	0.000109	0.0311	CrCbGaD
Pitavastatin—Rash—Fosphenytoin—epilepsy syndrome	0.000108	0.000891	CcSEcCtD
Pitavastatin—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000108	0.00089	CcSEcCtD
Pitavastatin—Asthenia—Clonazepam—epilepsy syndrome	0.000108	0.000888	CcSEcCtD
Pitavastatin—Back pain—Gabapentin—epilepsy syndrome	0.000107	0.000885	CcSEcCtD
Pitavastatin—Headache—Fosphenytoin—epilepsy syndrome	0.000107	0.000885	CcSEcCtD
Pitavastatin—Hepatitis—Topiramate—epilepsy syndrome	0.000107	0.000885	CcSEcCtD
Pitavastatin—Asthenia—Phenytoin—epilepsy syndrome	0.000107	0.000882	CcSEcCtD
Pitavastatin—Nausea—Midazolam—epilepsy syndrome	0.000107	0.00088	CcSEcCtD
Pitavastatin—Hypoaesthesia—Topiramate—epilepsy syndrome	0.000107	0.00088	CcSEcCtD
Pitavastatin—Muscle spasms—Gabapentin—epilepsy syndrome	0.000107	0.00088	CcSEcCtD
Pitavastatin—Diarrhoea—Zonisamide—epilepsy syndrome	0.000106	0.000879	CcSEcCtD
Pitavastatin—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000106	0.000877	CcSEcCtD
Pitavastatin—Pruritus—Clonazepam—epilepsy syndrome	0.000106	0.000876	CcSEcCtD
Pitavastatin—Pruritus—Phenytoin—epilepsy syndrome	0.000105	0.00087	CcSEcCtD
Pitavastatin—Nausea—Levetiracetam—epilepsy syndrome	0.000105	0.000869	CcSEcCtD
Pitavastatin—Rash—Vigabatrin—epilepsy syndrome	0.000105	0.000868	CcSEcCtD
Pitavastatin—Dizziness—Felbamate—epilepsy syndrome	0.000105	0.000868	CcSEcCtD
Pitavastatin—Dermatitis—Vigabatrin—epilepsy syndrome	0.000105	0.000867	CcSEcCtD
Pitavastatin—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000105	0.000865	CcSEcCtD
Pitavastatin—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000105	0.000865	CcSEcCtD
Pitavastatin—Headache—Vigabatrin—epilepsy syndrome	0.000105	0.000863	CcSEcCtD
Pitavastatin—ABCG2—medulla oblongata—epilepsy syndrome	0.000104	0.0172	CbGeAlD
Pitavastatin—Rash—Diazepam—epilepsy syndrome	0.000104	0.000855	CcSEcCtD
Pitavastatin—Dermatitis—Diazepam—epilepsy syndrome	0.000103	0.000854	CcSEcCtD
Pitavastatin—Myalgia—Pregabalin—epilepsy syndrome	0.000103	0.00085	CcSEcCtD
Pitavastatin—Arthralgia—Pregabalin—epilepsy syndrome	0.000103	0.00085	CcSEcCtD
Pitavastatin—Ill-defined disorder—Gabapentin—epilepsy syndrome	0.000103	0.000849	CcSEcCtD
Pitavastatin—Dizziness—Zonisamide—epilepsy syndrome	0.000103	0.000849	CcSEcCtD
Pitavastatin—Headache—Diazepam—epilepsy syndrome	0.000103	0.000849	CcSEcCtD
Pitavastatin—Diarrhoea—Clonazepam—epilepsy syndrome	0.000103	0.000847	CcSEcCtD
Pitavastatin—Asthenia—Carbamazepine—epilepsy syndrome	0.000102	0.000842	CcSEcCtD
Pitavastatin—Diarrhoea—Phenytoin—epilepsy syndrome	0.000102	0.000841	CcSEcCtD
Pitavastatin—Discomfort—Pregabalin—epilepsy syndrome	0.000102	0.00084	CcSEcCtD
Pitavastatin—Nausea—Fosphenytoin—epilepsy syndrome	0.000102	0.000839	CcSEcCtD
Pitavastatin—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000101	0.000837	CcSEcCtD
Pitavastatin—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000101	0.000836	CcSEcCtD
Pitavastatin—Pruritus—Carbamazepine—epilepsy syndrome	0.000101	0.00083	CcSEcCtD
Pitavastatin—Rash—Felbamate—epilepsy syndrome	0.0001	0.000827	CcSEcCtD
Pitavastatin—Dermatitis—Felbamate—epilepsy syndrome	0.0001	0.000826	CcSEcCtD
Pitavastatin—Malaise—Gabapentin—epilepsy syndrome	0.0001	0.000826	CcSEcCtD
Pitavastatin—Headache—Felbamate—epilepsy syndrome	9.96e-05	0.000822	CcSEcCtD
Pitavastatin—Confusional state—Pregabalin—epilepsy syndrome	9.96e-05	0.000822	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	9.95e-05	0.000821	CcSEcCtD
Pitavastatin—Dizziness—Clonazepam—epilepsy syndrome	9.92e-05	0.000818	CcSEcCtD
Pitavastatin—Nausea—Vigabatrin—epilepsy syndrome	9.91e-05	0.000818	CcSEcCtD
Pitavastatin—Insomnia—Valproic Acid—epilepsy syndrome	9.88e-05	0.000815	CcSEcCtD
Pitavastatin—Asthenia—Lamotrigine—epilepsy syndrome	9.86e-05	0.000814	CcSEcCtD
Pitavastatin—Dizziness—Phenytoin—epilepsy syndrome	9.85e-05	0.000813	CcSEcCtD
Pitavastatin—Rash—Zonisamide—epilepsy syndrome	9.81e-05	0.00081	CcSEcCtD
Pitavastatin—Dermatitis—Zonisamide—epilepsy syndrome	9.8e-05	0.000809	CcSEcCtD
Pitavastatin—Dizziness—Oxcarbazepine—epilepsy syndrome	9.8e-05	0.000809	CcSEcCtD
Pitavastatin—Nausea—Diazepam—epilepsy syndrome	9.76e-05	0.000805	CcSEcCtD
Pitavastatin—Headache—Zonisamide—epilepsy syndrome	9.75e-05	0.000804	CcSEcCtD
Pitavastatin—Diarrhoea—Carbamazepine—epilepsy syndrome	9.73e-05	0.000803	CcSEcCtD
Pitavastatin—Pruritus—Lamotrigine—epilepsy syndrome	9.72e-05	0.000802	CcSEcCtD
Pitavastatin—Dyspepsia—Valproic Acid—epilepsy syndrome	9.61e-05	0.000793	CcSEcCtD
Pitavastatin—SLCO2B1—brain—epilepsy syndrome	9.59e-05	0.0158	CbGeAlD
Pitavastatin—ABCG2—midbrain—epilepsy syndrome	9.54e-05	0.0157	CbGeAlD
Pitavastatin—Rash—Clonazepam—epilepsy syndrome	9.46e-05	0.00078	CcSEcCtD
Pitavastatin—Dermatitis—Clonazepam—epilepsy syndrome	9.45e-05	0.00078	CcSEcCtD
Pitavastatin—Arthralgia—Gabapentin—epilepsy syndrome	9.44e-05	0.000779	CcSEcCtD
Pitavastatin—Myalgia—Gabapentin—epilepsy syndrome	9.44e-05	0.000779	CcSEcCtD
Pitavastatin—Nausea—Felbamate—epilepsy syndrome	9.44e-05	0.000779	CcSEcCtD
Pitavastatin—Fatigue—Valproic Acid—epilepsy syndrome	9.42e-05	0.000777	CcSEcCtD
Pitavastatin—Dizziness—Carbamazepine—epilepsy syndrome	9.4e-05	0.000776	CcSEcCtD
Pitavastatin—Diarrhoea—Lamotrigine—epilepsy syndrome	9.4e-05	0.000776	CcSEcCtD
Pitavastatin—Headache—Clonazepam—epilepsy syndrome	9.4e-05	0.000775	CcSEcCtD
Pitavastatin—Rash—Phenytoin—epilepsy syndrome	9.39e-05	0.000775	CcSEcCtD
Pitavastatin—Dermatitis—Phenytoin—epilepsy syndrome	9.38e-05	0.000774	CcSEcCtD
Pitavastatin—Rash—Oxcarbazepine—epilepsy syndrome	9.34e-05	0.000771	CcSEcCtD
Pitavastatin—Constipation—Valproic Acid—epilepsy syndrome	9.34e-05	0.000771	CcSEcCtD
Pitavastatin—Dermatitis—Oxcarbazepine—epilepsy syndrome	9.34e-05	0.00077	CcSEcCtD
Pitavastatin—Headache—Phenytoin—epilepsy syndrome	9.33e-05	0.00077	CcSEcCtD
Pitavastatin—Discomfort—Gabapentin—epilepsy syndrome	9.33e-05	0.00077	CcSEcCtD
Pitavastatin—ABCG2—spinal cord—epilepsy syndrome	9.31e-05	0.0153	CbGeAlD
Pitavastatin—Headache—Oxcarbazepine—epilepsy syndrome	9.28e-05	0.000766	CcSEcCtD
Pitavastatin—Nausea—Zonisamide—epilepsy syndrome	9.24e-05	0.000763	CcSEcCtD
Pitavastatin—Confusional state—Gabapentin—epilepsy syndrome	9.13e-05	0.000753	CcSEcCtD
Pitavastatin—Dizziness—Lamotrigine—epilepsy syndrome	9.09e-05	0.00075	CcSEcCtD
Pitavastatin—Back pain—Topiramate—epilepsy syndrome	9.03e-05	0.000745	CcSEcCtD
Pitavastatin—Feeling abnormal—Valproic Acid—epilepsy syndrome	9e-05	0.000743	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	9e-05	0.000742	CcSEcCtD
Pitavastatin—Muscle spasms—Topiramate—epilepsy syndrome	8.97e-05	0.00074	CcSEcCtD
Pitavastatin—Rash—Carbamazepine—epilepsy syndrome	8.97e-05	0.00074	CcSEcCtD
Pitavastatin—Dermatitis—Carbamazepine—epilepsy syndrome	8.96e-05	0.000739	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	8.93e-05	0.000737	CcSEcCtD
Pitavastatin—Insomnia—Pregabalin—epilepsy syndrome	8.93e-05	0.000737	CcSEcCtD
Pitavastatin—Nausea—Clonazepam—epilepsy syndrome	8.91e-05	0.000735	CcSEcCtD
Pitavastatin—Headache—Carbamazepine—epilepsy syndrome	8.91e-05	0.000735	CcSEcCtD
Pitavastatin—Nausea—Phenytoin—epilepsy syndrome	8.85e-05	0.00073	CcSEcCtD
Pitavastatin—Nausea—Oxcarbazepine—epilepsy syndrome	8.8e-05	0.000726	CcSEcCtD
Pitavastatin—ALB—brain—epilepsy syndrome	8.78e-05	0.0144	CbGeAlD
Pitavastatin—Urticaria—Valproic Acid—epilepsy syndrome	8.68e-05	0.000716	CcSEcCtD
Pitavastatin—Rash—Lamotrigine—epilepsy syndrome	8.67e-05	0.000715	CcSEcCtD
Pitavastatin—Ill-defined disorder—Topiramate—epilepsy syndrome	8.66e-05	0.000715	CcSEcCtD
Pitavastatin—Dermatitis—Lamotrigine—epilepsy syndrome	8.66e-05	0.000714	CcSEcCtD
Pitavastatin—Abdominal pain—Valproic Acid—epilepsy syndrome	8.63e-05	0.000712	CcSEcCtD
Pitavastatin—Headache—Lamotrigine—epilepsy syndrome	8.61e-05	0.00071	CcSEcCtD
Pitavastatin—Fatigue—Pregabalin—epilepsy syndrome	8.51e-05	0.000702	CcSEcCtD
Pitavastatin—Nausea—Carbamazepine—epilepsy syndrome	8.45e-05	0.000697	CcSEcCtD
Pitavastatin—Constipation—Pregabalin—epilepsy syndrome	8.44e-05	0.000697	CcSEcCtD
Pitavastatin—Malaise—Topiramate—epilepsy syndrome	8.42e-05	0.000695	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	8.25e-05	0.000681	CcSEcCtD
Pitavastatin—Insomnia—Gabapentin—epilepsy syndrome	8.19e-05	0.000676	CcSEcCtD
Pitavastatin—Nausea—Lamotrigine—epilepsy syndrome	8.16e-05	0.000674	CcSEcCtD
Pitavastatin—Feeling abnormal—Pregabalin—epilepsy syndrome	8.14e-05	0.000671	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Pregabalin—epilepsy syndrome	8.07e-05	0.000666	CcSEcCtD
Pitavastatin—Hypersensitivity—Valproic Acid—epilepsy syndrome	8.05e-05	0.000664	CcSEcCtD
Pitavastatin—Dyspepsia—Gabapentin—epilepsy syndrome	7.97e-05	0.000658	CcSEcCtD
Pitavastatin—Myalgia—Topiramate—epilepsy syndrome	7.95e-05	0.000656	CcSEcCtD
Pitavastatin—Arthralgia—Topiramate—epilepsy syndrome	7.95e-05	0.000656	CcSEcCtD
Pitavastatin—Discomfort—Topiramate—epilepsy syndrome	7.85e-05	0.000648	CcSEcCtD
Pitavastatin—Urticaria—Pregabalin—epilepsy syndrome	7.84e-05	0.000647	CcSEcCtD
Pitavastatin—Asthenia—Valproic Acid—epilepsy syndrome	7.84e-05	0.000647	CcSEcCtD
Pitavastatin—Fatigue—Gabapentin—epilepsy syndrome	7.81e-05	0.000644	CcSEcCtD
Pitavastatin—Abdominal pain—Pregabalin—epilepsy syndrome	7.81e-05	0.000644	CcSEcCtD
Pitavastatin—Constipation—Gabapentin—epilepsy syndrome	7.74e-05	0.000639	CcSEcCtD
Pitavastatin—Pruritus—Valproic Acid—epilepsy syndrome	7.73e-05	0.000638	CcSEcCtD
Pitavastatin—Confusional state—Topiramate—epilepsy syndrome	7.68e-05	0.000634	CcSEcCtD
Pitavastatin—Diarrhoea—Valproic Acid—epilepsy syndrome	7.47e-05	0.000617	CcSEcCtD
Pitavastatin—Feeling abnormal—Gabapentin—epilepsy syndrome	7.46e-05	0.000616	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Gabapentin—epilepsy syndrome	7.4e-05	0.000611	CcSEcCtD
Pitavastatin—ABCG2—cerebellum—epilepsy syndrome	7.38e-05	0.0122	CbGeAlD
Pitavastatin—Hypersensitivity—Pregabalin—epilepsy syndrome	7.27e-05	0.0006	CcSEcCtD
Pitavastatin—Dizziness—Valproic Acid—epilepsy syndrome	7.22e-05	0.000596	CcSEcCtD
Pitavastatin—Urticaria—Gabapentin—epilepsy syndrome	7.19e-05	0.000594	CcSEcCtD
Pitavastatin—Abdominal pain—Gabapentin—epilepsy syndrome	7.16e-05	0.000591	CcSEcCtD
Pitavastatin—ABCB1—forebrain—epilepsy syndrome	7.13e-05	0.0117	CbGeAlD
Pitavastatin—Asthenia—Pregabalin—epilepsy syndrome	7.08e-05	0.000585	CcSEcCtD
Pitavastatin—Pruritus—Pregabalin—epilepsy syndrome	6.99e-05	0.000576	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	6.94e-05	0.000573	CcSEcCtD
Pitavastatin—Insomnia—Topiramate—epilepsy syndrome	6.89e-05	0.000568	CcSEcCtD
Pitavastatin—Rash—Valproic Acid—epilepsy syndrome	6.89e-05	0.000568	CcSEcCtD
Pitavastatin—Dermatitis—Valproic Acid—epilepsy syndrome	6.88e-05	0.000568	CcSEcCtD
Pitavastatin—Headache—Valproic Acid—epilepsy syndrome	6.84e-05	0.000565	CcSEcCtD
Pitavastatin—Diarrhoea—Pregabalin—epilepsy syndrome	6.76e-05	0.000557	CcSEcCtD
Pitavastatin—Dyspepsia—Topiramate—epilepsy syndrome	6.71e-05	0.000553	CcSEcCtD
Pitavastatin—Hypersensitivity—Gabapentin—epilepsy syndrome	6.67e-05	0.00055	CcSEcCtD
Pitavastatin—Fatigue—Topiramate—epilepsy syndrome	6.57e-05	0.000542	CcSEcCtD
Pitavastatin—ABCB1—telencephalon—epilepsy syndrome	6.55e-05	0.0108	CbGeAlD
Pitavastatin—Dizziness—Pregabalin—epilepsy syndrome	6.53e-05	0.000539	CcSEcCtD
Pitavastatin—Constipation—Topiramate—epilepsy syndrome	6.51e-05	0.000537	CcSEcCtD
Pitavastatin—Asthenia—Gabapentin—epilepsy syndrome	6.5e-05	0.000536	CcSEcCtD
Pitavastatin—Nausea—Valproic Acid—epilepsy syndrome	6.49e-05	0.000535	CcSEcCtD
Pitavastatin—Pruritus—Gabapentin—epilepsy syndrome	6.41e-05	0.000529	CcSEcCtD
Pitavastatin—Feeling abnormal—Topiramate—epilepsy syndrome	6.28e-05	0.000518	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Topiramate—epilepsy syndrome	6.23e-05	0.000514	CcSEcCtD
Pitavastatin—Rash—Pregabalin—epilepsy syndrome	6.23e-05	0.000514	CcSEcCtD
Pitavastatin—Dermatitis—Pregabalin—epilepsy syndrome	6.22e-05	0.000513	CcSEcCtD
Pitavastatin—Diarrhoea—Gabapentin—epilepsy syndrome	6.19e-05	0.000511	CcSEcCtD
Pitavastatin—Headache—Pregabalin—epilepsy syndrome	6.19e-05	0.00051	CcSEcCtD
Pitavastatin—CYP2C8—brain—epilepsy syndrome	6.17e-05	0.0102	CbGeAlD
Pitavastatin—Urticaria—Topiramate—epilepsy syndrome	6.05e-05	0.000499	CcSEcCtD
Pitavastatin—Abdominal pain—Topiramate—epilepsy syndrome	6.02e-05	0.000497	CcSEcCtD
Pitavastatin—ABCG2—brain—epilepsy syndrome	6e-05	0.00987	CbGeAlD
Pitavastatin—Dizziness—Gabapentin—epilepsy syndrome	5.99e-05	0.000494	CcSEcCtD
Pitavastatin—Nausea—Pregabalin—epilepsy syndrome	5.86e-05	0.000484	CcSEcCtD
Pitavastatin—Rash—Gabapentin—epilepsy syndrome	5.71e-05	0.000471	CcSEcCtD
Pitavastatin—Dermatitis—Gabapentin—epilepsy syndrome	5.7e-05	0.000471	CcSEcCtD
Pitavastatin—Headache—Gabapentin—epilepsy syndrome	5.67e-05	0.000468	CcSEcCtD
Pitavastatin—Hypersensitivity—Topiramate—epilepsy syndrome	5.61e-05	0.000463	CcSEcCtD
Pitavastatin—Asthenia—Topiramate—epilepsy syndrome	5.47e-05	0.000451	CcSEcCtD
Pitavastatin—Pruritus—Topiramate—epilepsy syndrome	5.39e-05	0.000445	CcSEcCtD
Pitavastatin—Nausea—Gabapentin—epilepsy syndrome	5.38e-05	0.000444	CcSEcCtD
Pitavastatin—Diarrhoea—Topiramate—epilepsy syndrome	5.21e-05	0.00043	CcSEcCtD
Pitavastatin—ABCB1—medulla oblongata—epilepsy syndrome	5.15e-05	0.00848	CbGeAlD
Pitavastatin—Dizziness—Topiramate—epilepsy syndrome	5.04e-05	0.000416	CcSEcCtD
Pitavastatin—Rash—Topiramate—epilepsy syndrome	4.8e-05	0.000396	CcSEcCtD
Pitavastatin—Dermatitis—Topiramate—epilepsy syndrome	4.8e-05	0.000396	CcSEcCtD
Pitavastatin—Headache—Topiramate—epilepsy syndrome	4.77e-05	0.000394	CcSEcCtD
Pitavastatin—ABCB1—midbrain—epilepsy syndrome	4.71e-05	0.00775	CbGeAlD
Pitavastatin—ABCB1—spinal cord—epilepsy syndrome	4.59e-05	0.00756	CbGeAlD
Pitavastatin—Nausea—Topiramate—epilepsy syndrome	4.52e-05	0.000373	CcSEcCtD
Pitavastatin—ABCB1—head—epilepsy syndrome	4.08e-05	0.00672	CbGeAlD
Pitavastatin—ABCB1—nervous system—epilepsy syndrome	3.87e-05	0.00637	CbGeAlD
Pitavastatin—ABCB1—central nervous system—epilepsy syndrome	3.72e-05	0.00613	CbGeAlD
Pitavastatin—ABCB1—cerebellum—epilepsy syndrome	3.64e-05	0.00599	CbGeAlD
Pitavastatin—ABCB1—brain—epilepsy syndrome	2.96e-05	0.00487	CbGeAlD
Pitavastatin—HMGCR—Metabolism—APOE—epilepsy syndrome	6.67e-06	9.25e-05	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	6.66e-06	9.23e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	6.64e-06	9.21e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ATIC—epilepsy syndrome	6.61e-06	9.17e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—NEU1—epilepsy syndrome	6.61e-06	9.17e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—UPB1—epilepsy syndrome	6.61e-06	9.17e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—CAT—epilepsy syndrome	6.59e-06	9.14e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GBE1—epilepsy syndrome	6.58e-06	9.12e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PPP1R3C—epilepsy syndrome	6.58e-06	9.12e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—CDC42—epilepsy syndrome	6.48e-06	8.98e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CACNA1A—epilepsy syndrome	6.42e-06	8.91e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ALDH7A1—epilepsy syndrome	6.42e-06	8.91e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—ABCB1—epilepsy syndrome	6.42e-06	8.89e-05	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—ALB—epilepsy syndrome	6.41e-06	8.88e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—ALDH7A1—epilepsy syndrome	6.39e-06	8.85e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CACNA1A—epilepsy syndrome	6.39e-06	8.85e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—HSD17B4—epilepsy syndrome	6.37e-06	8.83e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	6.35e-06	8.8e-05	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—GPX1—epilepsy syndrome	6.33e-06	8.77e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ST3GAL3—epilepsy syndrome	6.29e-06	8.71e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—ST3GAL3—epilepsy syndrome	6.25e-06	8.67e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—CYP2C19—epilepsy syndrome	6.23e-06	8.64e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—CYP11A1—epilepsy syndrome	6.19e-06	8.59e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ASAH1—epilepsy syndrome	6.19e-06	8.58e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ADSL—epilepsy syndrome	6.16e-06	8.54e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PPP1R3C—epilepsy syndrome	6.15e-06	8.52e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GBE1—epilepsy syndrome	6.15e-06	8.52e-05	CbGpPWpGaD
Pitavastatin—ABCC2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	6.13e-06	8.5e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—ADSL—epilepsy syndrome	6.12e-06	8.49e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	6.12e-06	8.48e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	6.05e-06	8.39e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GLUL—epilepsy syndrome	6.04e-06	8.37e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—CYP2D6—epilepsy syndrome	6.04e-06	8.37e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—HMOX1—epilepsy syndrome	6.03e-06	8.36e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—STXBP1—epilepsy syndrome	6.02e-06	8.35e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	6.01e-06	8.33e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GLUL—epilepsy syndrome	6.01e-06	8.33e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—GPX1—epilepsy syndrome	5.96e-06	8.27e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—CAT—epilepsy syndrome	5.95e-06	8.25e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CACNA1D—epilepsy syndrome	5.93e-06	8.22e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	5.89e-06	8.17e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CACNA1D—epilepsy syndrome	5.89e-06	8.17e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—NT5E—epilepsy syndrome	5.87e-06	8.13e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ALAD—epilepsy syndrome	5.87e-06	8.13e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	5.84e-06	8.09e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—ABCB1—epilepsy syndrome	5.79e-06	8.02e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ASAH1—epilepsy syndrome	5.78e-06	8.01e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—FYN—epilepsy syndrome	5.77e-06	7.99e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	5.76e-06	7.98e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—ADRA2A—epilepsy syndrome	5.75e-06	7.97e-05	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—POMC—epilepsy syndrome	5.73e-06	7.94e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	5.73e-06	7.94e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—BCHE—epilepsy syndrome	5.72e-06	7.93e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	5.62e-06	7.8e-05	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—PTGS2—epilepsy syndrome	5.61e-06	7.77e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CACNA1A—epilepsy syndrome	5.6e-06	7.76e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ALDH7A1—epilepsy syndrome	5.6e-06	7.76e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—CYP2D6—epilepsy syndrome	5.59e-06	7.75e-05	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—AGT—epilepsy syndrome	5.55e-06	7.69e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—TXNRD1—epilepsy syndrome	5.54e-06	7.69e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—YWHAZ—epilepsy syndrome	5.54e-06	7.69e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—TXNRD1—epilepsy syndrome	5.51e-06	7.64e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—NT5E—epilepsy syndrome	5.48e-06	7.6e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ALAD—epilepsy syndrome	5.48e-06	7.6e-05	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	5.48e-06	7.59e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	5.48e-06	7.59e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—SLC2A1—epilepsy syndrome	5.46e-06	7.57e-05	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—APOE—epilepsy syndrome	5.44e-06	7.54e-05	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—AVP—epilepsy syndrome	5.43e-06	7.53e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PLCB1—epilepsy syndrome	5.4e-06	7.49e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—AQP1—epilepsy syndrome	5.38e-06	7.46e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—GPX1—epilepsy syndrome	5.38e-06	7.46e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—TH—epilepsy syndrome	5.38e-06	7.46e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ADSL—epilepsy syndrome	5.37e-06	7.44e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—AQP1—epilepsy syndrome	5.35e-06	7.42e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	5.33e-06	7.39e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—ADRA2A—epilepsy syndrome	5.32e-06	7.38e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—BCHE—epilepsy syndrome	5.3e-06	7.35e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	5.3e-06	7.34e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GLUL—epilepsy syndrome	5.26e-06	7.29e-05	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	5.26e-06	7.29e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—AGT—epilepsy syndrome	5.23e-06	7.25e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	5.23e-06	7.25e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	5.23e-06	7.25e-05	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—ALB—epilepsy syndrome	5.22e-06	7.24e-05	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—SRC—epilepsy syndrome	5.22e-06	7.23e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	5.17e-06	7.17e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	5.16e-06	7.16e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	5.14e-06	7.13e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	5.14e-06	7.12e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—APOE—epilepsy syndrome	5.12e-06	7.1e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	5.12e-06	7.09e-05	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—VEGFA—epilepsy syndrome	5.08e-06	7.04e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—SLC2A1—epilepsy syndrome	5.05e-06	7.01e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ADSL—epilepsy syndrome	5.01e-06	6.95e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	5e-06	6.93e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PLCB1—epilepsy syndrome	5e-06	6.93e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—TH—epilepsy syndrome	4.98e-06	6.91e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—PLAU—epilepsy syndrome	4.92e-06	6.82e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GLUL—epilepsy syndrome	4.92e-06	6.81e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—KCNJ11—epilepsy syndrome	4.87e-06	6.75e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CHRM3—epilepsy syndrome	4.87e-06	6.75e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CHRM3—epilepsy syndrome	4.84e-06	6.71e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—KCNJ11—epilepsy syndrome	4.84e-06	6.71e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	4.83e-06	6.7e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	4.82e-06	6.69e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	4.8e-06	6.65e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	4.76e-06	6.59e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—AGT—epilepsy syndrome	4.72e-06	6.54e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—AQP1—epilepsy syndrome	4.69e-06	6.5e-05	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—POMC—epilepsy syndrome	4.67e-06	6.48e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—APOE—epilepsy syndrome	4.62e-06	6.41e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—PRKCB—epilepsy syndrome	4.58e-06	6.34e-05	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—PTGS2—epilepsy syndrome	4.57e-06	6.34e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.53e-06	6.28e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—NOS2—epilepsy syndrome	4.52e-06	6.27e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	4.51e-06	6.26e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.51e-06	6.25e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—HMOX1—epilepsy syndrome	4.49e-06	6.23e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.44e-06	6.16e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—CAT—epilepsy syndrome	4.43e-06	6.14e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.42e-06	6.12e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—POMC—epilepsy syndrome	4.4e-06	6.1e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—AQP1—epilepsy syndrome	4.38e-06	6.07e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—ABCB1—epilepsy syndrome	4.31e-06	5.98e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	4.29e-06	5.94e-05	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—ALB—epilepsy syndrome	4.26e-06	5.9e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CHRM3—epilepsy syndrome	4.24e-06	5.88e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	4.24e-06	5.88e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	4.21e-06	5.83e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—HMOX1—epilepsy syndrome	4.16e-06	5.76e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—CAT—epilepsy syndrome	4.1e-06	5.69e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—ALB—epilepsy syndrome	4.01e-06	5.56e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—GPX1—epilepsy syndrome	4.01e-06	5.55e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—ABCB1—epilepsy syndrome	3.99e-06	5.53e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—POMC—epilepsy syndrome	3.97e-06	5.51e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ABCG2—epilepsy syndrome	3.97e-06	5.5e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	3.96e-06	5.49e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	3.96e-06	5.49e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—ABCG2—epilepsy syndrome	3.95e-06	5.47e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CYP2C19—epilepsy syndrome	3.87e-06	5.36e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CYP2C19—epilepsy syndrome	3.85e-06	5.33e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CYP11A1—epilepsy syndrome	3.84e-06	5.33e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CYP11A1—epilepsy syndrome	3.82e-06	5.3e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.82e-06	5.29e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.79e-06	5.26e-05	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PTGS2—epilepsy syndrome	3.73e-06	5.16e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—GPX1—epilepsy syndrome	3.71e-06	5.14e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.69e-06	5.12e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—ALB—epilepsy syndrome	3.62e-06	5.02e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.62e-06	5.01e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—AGT—epilepsy syndrome	3.51e-06	4.87e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PTGS2—epilepsy syndrome	3.51e-06	4.87e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.48e-06	4.82e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	3.47e-06	4.81e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ABCG2—epilepsy syndrome	3.46e-06	4.79e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CYP2D6—epilepsy syndrome	3.45e-06	4.78e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—APOE—epilepsy syndrome	3.44e-06	4.77e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	3.37e-06	4.67e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	3.35e-06	4.64e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	3.3e-06	4.58e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—BCHE—epilepsy syndrome	3.29e-06	4.56e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—ADRA2A—epilepsy syndrome	3.28e-06	4.55e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—BCHE—epilepsy syndrome	3.27e-06	4.53e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—AGT—epilepsy syndrome	3.25e-06	4.51e-05	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	3.24e-06	4.49e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	3.23e-06	4.48e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	3.19e-06	4.42e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—APOE—epilepsy syndrome	3.19e-06	4.42e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PTGS2—epilepsy syndrome	3.17e-06	4.39e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	3.15e-06	4.36e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	3.14e-06	4.35e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	3.13e-06	4.34e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—SLC2A1—epilepsy syndrome	3.12e-06	4.32e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.11e-06	4.31e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	3.1e-06	4.3e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—TH—epilepsy syndrome	3.09e-06	4.29e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PLCB1—epilepsy syndrome	3.09e-06	4.28e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—TH—epilepsy syndrome	3.07e-06	4.26e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.04e-06	4.22e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.03e-06	4.2e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	3.02e-06	4.19e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—POMC—epilepsy syndrome	2.96e-06	4.1e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.88e-06	4e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	2.88e-06	3.99e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—BCHE—epilepsy syndrome	2.86e-06	3.97e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.83e-06	3.93e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	2.82e-06	3.91e-05	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—AKT1—epilepsy syndrome	2.82e-06	3.91e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—POMC—epilepsy syndrome	2.74e-06	3.8e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	2.73e-06	3.79e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PLCB1—epilepsy syndrome	2.7e-06	3.75e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—ALB—epilepsy syndrome	2.7e-06	3.74e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—TH—epilepsy syndrome	2.69e-06	3.73e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—SRC—epilepsy syndrome	2.69e-06	3.73e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	2.69e-06	3.73e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—BCHE—epilepsy syndrome	2.68e-06	3.71e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—VEGFA—epilepsy syndrome	2.62e-06	3.63e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	2.58e-06	3.58e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—HMOX1—epilepsy syndrome	2.57e-06	3.56e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	2.55e-06	3.54e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CAT—epilepsy syndrome	2.55e-06	3.53e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CAT—epilepsy syndrome	2.53e-06	3.51e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	2.53e-06	3.5e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—TH—epilepsy syndrome	2.52e-06	3.49e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—ALB—epilepsy syndrome	2.5e-06	3.46e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.48e-06	3.43e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	2.48e-06	3.43e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—ABCB1—epilepsy syndrome	2.46e-06	3.41e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PTGS2—epilepsy syndrome	2.36e-06	3.27e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GPX1—epilepsy syndrome	2.3e-06	3.19e-05	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—AKT1—epilepsy syndrome	2.3e-06	3.18e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GPX1—epilepsy syndrome	2.29e-06	3.17e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—HMOX1—epilepsy syndrome	2.25e-06	3.12e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CAT—epilepsy syndrome	2.22e-06	3.07e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PTGS2—epilepsy syndrome	2.18e-06	3.03e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	2.1e-06	2.91e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CAT—epilepsy syndrome	2.07e-06	2.87e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—AGT—epilepsy syndrome	2.02e-06	2.8e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	2.02e-06	2.79e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—AGT—epilepsy syndrome	2.01e-06	2.78e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GPX1—epilepsy syndrome	2.01e-06	2.78e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—APOE—epilepsy syndrome	1.98e-06	2.74e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—APOE—epilepsy syndrome	1.97e-06	2.73e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GPX1—epilepsy syndrome	1.87e-06	2.6e-05	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—AKT1—epilepsy syndrome	1.87e-06	2.6e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—AKT1—epilepsy syndrome	1.76e-06	2.45e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—AGT—epilepsy syndrome	1.76e-06	2.44e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—APOE—epilepsy syndrome	1.72e-06	2.39e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—POMC—epilepsy syndrome	1.7e-06	2.36e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—POMC—epilepsy syndrome	1.69e-06	2.34e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—AKT1—epilepsy syndrome	1.67e-06	2.32e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—AGT—epilepsy syndrome	1.64e-06	2.28e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—APOE—epilepsy syndrome	1.61e-06	2.23e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—AKT1—epilepsy syndrome	1.59e-06	2.21e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ALB—epilepsy syndrome	1.55e-06	2.15e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—POMC—epilepsy syndrome	1.48e-06	2.05e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—POMC—epilepsy syndrome	1.38e-06	1.92e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	1.36e-06	1.88e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ALB—epilepsy syndrome	1.35e-06	1.87e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PTGS2—epilepsy syndrome	1.35e-06	1.87e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ALB—epilepsy syndrome	1.26e-06	1.75e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—AKT1—epilepsy syndrome	1.19e-06	1.64e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PTGS2—epilepsy syndrome	1.18e-06	1.64e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	1.1e-06	1.53e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—AKT1—epilepsy syndrome	1.1e-06	1.52e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—AKT1—epilepsy syndrome	6.81e-07	9.44e-06	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—AKT1—epilepsy syndrome	6.77e-07	9.39e-06	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—AKT1—epilepsy syndrome	5.94e-07	8.23e-06	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—AKT1—epilepsy syndrome	5.54e-07	7.69e-06	CbGpPWpGaD
